Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

Delayed Data
As of Nov 24
 +0.0904 / +14.58%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Cyclacel Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +603.83% increase from the last price of 0.71.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Cyclacel Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 22

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 0.00%
Growthannually 51.69%


Growthquarterly -28.95%
Growthannually 17.13%
Key to the earnings and sales forecast charts.